Onconova Therapeutics, Inc. Warrants
ONTXW
ONTXW was delisted on the 23rd of July, 2021.
4 hedge funds and large institutions have $1M invested in Onconova Therapeutics, Inc. Warrants in 2017 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
3,508% more capital inflows, than outflows
Capital inflows: $36.1K | Capital outflows: $1K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less funds holding
Funds holding: 5 → 4 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
+$36.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1K |
ONTXW Hedge Fund Activity: Q3 2017 in Review
4 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in Onconova Therapeutics, Inc. Warrants (ONTXW) for Q3 2017, worth a combined $1M — up 53% from $654K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ONTXW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was Boxer Capital, adding an estimated $36.1K. The largest seller was UBS Group, exiting entirely with an estimated $1K sold.
- 4 institutional investors held Onconova Therapeutics, Inc. Warrants (ONTXW) as of Q3 2017, down from 5 in Q2 2017.
- Funds reported $1M of Onconova Therapeutics, Inc. Warrants stock for Q3 2017, up 53% quarter-over-quarter.
- 0 funds opened new Onconova Therapeutics, Inc. Warrants positions in Q3 2017 and 1 closed out, a net change of -1 holder.
- The largest Onconova Therapeutics, Inc. Warrants buyer in Q3 2017 was Boxer Capital, an estimated $36.1K added.
- The largest Onconova Therapeutics, Inc. Warrants seller in Q3 2017 was UBS Group, an estimated $1K sold.
Based on aggregated 13F filings for Q3 2017.